Literature DB >> 4610077

Antigenic modulation in vitro. I. Fate of thymus-leukemia (TL) antigen-antibody complexes following modulation of TL antigenicity from the surfaces of mouse leukemia cells and thymocytes.

C W Stackpole, J B Jacobson, M P Lardis.   

Abstract

The modulation or loss of thymus-leukemia (TL) antigenicity from the surfaces of mouse RADA1 leukemia cells and normal thymocytes during incubation with TL antibody in vitro at 37 degrees C was investigated by cytotoxicity, immunofluorescence, and immunoelectron microscopy. The fate of bivalent and monovalent antibody during modulation was visualized by fluorescence microscopy. Considerable antibody remained bound to the cell surface after modulation, bivalent antibody being displaced topographically into "patches" and "caps" while monovalent antibody was only slightly aggregated on the cell surface. Some antibody was internalized, presumably by pinocytosis, and was sequestered into the Golgi region of the cell. Capping usually occurred over the pole of the cell opposite from the Golgi region, which may explain the lack of extensive pinocytosis of modulating bivalent antibody. Since modulation with monovalent antibody occurs without patch or cap formation, gross topographical redistribution of TL antigen-antibody complexes is not required for modulation, although more subtle displacement of these complexes may be involved. Modulation was demonstrable by cytotoxicity with guinea pig C' but not with absorbed rabbit C', indicating that modulated TL antigens remain bound to the cell surface. A heat-labile factor in TL antiserum and in mouse serum in general is responsible for "blocking" the cytolytic interaction of guinea pig C' with modulated TL antigen-antibody complexes.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4610077      PMCID: PMC2139632          DOI: 10.1084/jem.140.4.939

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  15 in total

1.  Histoincompatibility attributable to genes near H-2 that are not revealed by hemagglutination or cytotoxicity tests.

Authors:  E A Boyse; L Flaherty; E Stockert; L J Old
Journal:  Transplantation       Date:  1972-04       Impact factor: 4.939

2.  Modulation of TL (thymus-leukemia) antigens by Fab-fragments of TL antibody.

Authors:  M E Lamm; E A Boyse; L J Old; B Lisowska-Bernstein; E Stockert
Journal:  J Immunol       Date:  1968-07       Impact factor: 5.422

3.  Membrane permeability change by aggregation of mobile glycoprotein units.

Authors:  D Gingell
Journal:  J Theor Biol       Date:  1973-03       Impact factor: 2.691

4.  New visual markers of antibody for electron microscopy.

Authors:  U Hämmerling; T Aoki; H A Wood; L J Old; E A Boyse; E de Harvin
Journal:  Nature       Date:  1969-09-13       Impact factor: 49.962

5.  Modification of the antigenic structure of the cell membrane by thymus-leukemia (TL) antibody.

Authors:  E A Boyse; E Stockert; L J Old
Journal:  Proc Natl Acad Sci U S A       Date:  1967-09       Impact factor: 11.205

6.  A comment on the genetic data relating to expression of TL antigens.

Authors:  E A Boyse; L J Old
Journal:  Transplantation       Date:  1971-06       Impact factor: 4.939

7.  Chromatographic purification of tetramethylrhodamine-immune globulin conjugates and their use in the cellular localization of rabbit gamma-globulin polypeptide chains.

Authors:  J J Cebra; G Goldstein
Journal:  J Immunol       Date:  1965-08       Impact factor: 5.422

8.  Improved complementation in the cytotoxic test.

Authors:  E A Boyse; L Hubbard; E Stockert; M E Lamm
Journal:  Transplantation       Date:  1970-11       Impact factor: 4.939

9.  Evidence for surface-associated immunoglobulin on T and B lymphocytes.

Authors:  U Hämmerling; K Rajewsky
Journal:  Eur J Immunol       Date:  1971-12       Impact factor: 5.532

10.  Antigenic modulation. Loss of TL antigen from cells exposed to TL antibody. Study of the phenomenon in vitro.

Authors:  L J Old; E Stockert; E A Boyse; J H Kim
Journal:  J Exp Med       Date:  1968-03-01       Impact factor: 14.307

View more
  21 in total

1.  Antibody-induced modulation of Friend virus cell surface antigens decreases virus production by persistent erythroleukemia cells: influence of the Rfv-3 gene.

Authors:  B Chesebro; K Wehrly; D Doig; J Nishio
Journal:  Proc Natl Acad Sci U S A       Date:  1979-11       Impact factor: 11.205

2.  Inactivation or elimination of potentially trypanolytic, complement-activating immune complexes by pathogenic trypanosomes.

Authors:  A E Balber; J D Bangs; S M Jones; R L Proia
Journal:  Infect Immun       Date:  1979-06       Impact factor: 3.441

3.  Metabolic fate of monovalent and multivalent antibodies of Heymann nephritis following formation of surface immune complexes on glomerular epithelial cells.

Authors:  A K Singh; B S Kasinath
Journal:  Clin Exp Immunol       Date:  1993-12       Impact factor: 4.330

4.  Clearance of antibodies from rat sarcoma cell surfaces. Rate of clearance of alloantibodies depends on antibody isotype.

Authors:  S M Hobbs; J M Styles; C J Dean; P S Shepherd
Journal:  Immunology       Date:  1983-12       Impact factor: 7.397

5.  Surface mapping of mouse thymocytes.

Authors:  L Flaherty; D Zimmerman
Journal:  Proc Natl Acad Sci U S A       Date:  1979-04       Impact factor: 11.205

Review 6.  Treatment of lymphoid tumors with anti-idiotype antibodies.

Authors:  G T Stevenson; F K Stevenson
Journal:  Springer Semin Immunopathol       Date:  1983

7.  Antigenic modulation of lymphocytic surface immunoglobulin yielding resistance to complement-mediated lysis. II. Relationship to redistribution of the antigen.

Authors:  J Gordon; G T Stevenson
Journal:  Immunology       Date:  1981-01       Impact factor: 7.397

8.  Antigenic modulation of lymphocytic surface immunoglobulin yielding resistance to complement-mediated lysis. I. Characterization with syngeneic and xenogeneic complements.

Authors:  J Gordon; D S Robinson; G T Stevenson
Journal:  Immunology       Date:  1981-01       Impact factor: 7.397

9.  Monoclonal antibodies reactive with human myeloid leukaemia cells.

Authors:  E D Ball; M W Fanger
Journal:  Clin Exp Immunol       Date:  1982-06       Impact factor: 4.330

10.  Antibodies to varicella-zoster virus modulate antigen distribution but fail to induce viral persistence in vitro.

Authors:  C Sadzot-Delvaux; P Marc; L Lebon; M P Merville-Louis; J Piette; B Rentier
Journal:  J Virol       Date:  1992-12       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.